As the European Union (EU) ushers in a new era of health technology regulation, pharmaceutical companies face both unprecedented challenges and opportunities. At the heart of this transformation is ...
The way healthcare technology assessments (HTAs) are conducted in Europe is changing. In less than a year, all new advanced therapeutic products and oncology drugs will be subject to a mandatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback